Abstract
Aluminum (Al) exposure inhibits bone formation. Osteoblastic proliferation promotes bone formation. Therefore, we inferred that Al may inhibit bone formation by the inhibition of osteoblastic proliferation. However, the effects and molecular mechanisms of Al on osteoblastic proliferation are still under investigation. Osteoblastic proliferation can be regulated by Wnt/β-catenin signaling pathway. To investigate the effects of Al on osteoblastic proliferation and whether Wnt/β-catenin signaling pathway is involved in it, osteoblasts from neonatal rats were cultured and exposed to 0, 0.4 mM (1/20 IC50), 0.8 mM (1/10 IC50), and 1.6 mM (1/5 IC50) of aluminum trichloride (AlCl3) for 24 h, respectively. The osteoblastic proliferation rates; Wnt3a, lipoprotein receptor-related protein 5 (LRP-5), T cell factor 1 (TCF-1), cyclin D1, and c-Myc messenger RNA (mRNA) expressions; and p-glycogen synthase kinase 3β (GSK3β), GSK3β, and β-catenin protein expressions indicated that AlCl3 inhibited osteoblastic proliferation and downregulated Wnt/β-catenin signaling pathway. In addition, the AlCl3 concentration was negatively correlated with osteoblastic proliferation rates and the mRNA expressions of Wnt3a, c-Myc, and cyclin D1, while the osteoblastic proliferation rates were positively correlated with mRNA expressions of Wnt3a, c-Myc, and cyclin D1. Taken together, these findings indicated that AlCl3 inhibits osteoblastic proliferation may be associated with the inactivation of Wnt/β-catenin signaling pathway.
Similar content being viewed by others
References
Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM, Arnold IM, Momoli F, Krewski D (2014) Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol 44:1–80
Wesdock JC, Arnold IM (2014) Occupational and environmental health in the aluminum industry: key points for health practitioners. J Occup Environ Med 56:S5–11
Yokel RA, McNamara PJ (2001) Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol 88(4):159–167
Priest ND (2004) The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update. J Environ Monit 6(5):375–403
Li X, Zhang L, Zhu Y, Li Y (2011) Dynamic analysis of exposure to aluminum and an acidic condition on bone formation in young growing rats. Environ Toxicol Pharmacol 31:295–301
Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V (2007) Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 10:1–269
Kasai K, Hori MT, Goodman WG (1991) Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells. Am J Phys 260:E537–E543
Boyce BF, Byars J, McWilliams S, Mocan MZ, Elder HY, Boyle IT, Junor BJ (1992) Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia. J Clin Pathol 45:502–508
Jorgetti V, Soeiro NM, Mendes V, Pereira RC, Crivellari ME, Coutris G, Borelli A, Leite MO, Nussenzweig I, Marcondes M, Drüeke T, Cournot G (1994) Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus. Nephrol Dial Transplant 9:668–674
Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements—an overview. J Trace Elem Med Biol 26:149–152
Jeffery EH, Abreo K, Burgess E, Cannata J, Greger JL (1996) Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 48:649–665
Willhite CC, Ball GL, McLellan CJ (2012) Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Crit Rev Toxicol 42:358–442
Li S, Quarto N, Senarath-Yapa K, Grey N, Bai X, Longaker MT (2015) Enhanced activation of canonical wnt signaling confers mesoderm-derived parietal bone with similar osteogenic and skeletal healing capacity to neural crest-derived frontal bone. PLoS One 10:e0138059
Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501–1504
Cao Z, Fu Y, Sun X, Zhang Q, Xu F, Li Y (2016) Aluminum trichloride inhibits osteoblastic differentiation through inactivation of wnt/β-catenin signaling pathway in rat osteoblasts. Environ Toxicol Pharmacol 42:198–204
Song M, Huo H, Cao Z, Han Y, Gao L (2016) Aluminum trichloride inhibits the rat osteoblasts mineralization in vitro. Biol Trace Elem Res
Chen J, Qiu M, Dou C, Cao Z, Dong S (2015) MicroRNAs in bone balance and osteoporosis. Drug Dev Res 76:235–245
Huang LW, Ren L, Yang PF, Shang P (2015) Response of osteoblasts to the stimulus of fluid flow. Crit Rev Eukaryot Gene Expr 25(2):153–162
Marie PJ (1999) Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histol Histopathol 14(2):525–538
Marie PJ, Kassem M (2011) Osteoblasts in osteoporosis: past emerging and future anabolic targets. Eur J Endocrinol 165(1):1–10
Canalis E (2010) New treatment modalities in osteoporosis. Endocr Pract 16(5):855–863
Bellows CG, Aubin JE, Heersche JN (1995) Aluminum inhibits both initiation and progression of mineralization of osteoid nodules formed in differentiating rat calvaria cell cultures. J Bone Miner Res 10:2011–2016
Lieberherr M, Grosse B, Cournot-Witmer G, Hermann-Erlee MP, Balsan S (1987) Aluminum action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3. Kidney Int 31:736–743
Lau KH, Yoo A, Wang SP (1991) Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride. Mol Cell Biochem 105:93–105
Zha X, Xu Z, Liu Y, Xu L, Huang H, Zhang J, Cui L, Zhou C, Xu D (2016) Amentoflavone enhances osteogenesis of human mesenchymal stem cells through JNK and p38 MAPK pathways. J Nat Med 70:634–644
Hu H, Chen M, Dai G, Du G, Wang X, He J, Zhao Y, Han D, Cao Y, Zheng Y, Ding D (2016) An inhibitory role of osthole in rat MSCs osteogenic differentiation and proliferation via wnt/β-catenin and Erk1/2-MAPK pathways. Cell Physiol Biochem 38:2375–2388
Hu B, Yu B, Tang D, Li S, Wu Y (2016) Daidzein promotes osteoblast proliferation and differentiation in OCT1 cells through stimulating the activation of BMP-2/Smads pathway. Genet Mol Res 15. doi:10.4238/gmr.15028792
Salazar VS, Zarkadis N, Huang L, Watkins M, Kading J, Bonar S, Norris J, Mbalaviele G, Civitelli R (2013) Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical wnt signaling through interactions with β-catenin. J Cell Sci 126:5598–5609
Issack PS, Helfet DL, Lane JM (2008) Role of wnt signaling in bone remodeling and repair. HSS J 4:66–70
Zhai M, Jing D, Tong S, Wu Y, Wang P, Zeng Z, Shen G, Wang X, Xu Q, Luo E (2016) Pulsed electromagnetic fields promote in vitro osteoblastogenesis through a wnt/β-catenin signaling-associated mechanism. Bioelectromagnetics 37:152–162
Espada J, Calvo MB, Díaz-Prado S, Medina V (2009) Wnt signalling and cancer stem cells. Clin Transl Oncol 11:411–427
Chau JF, Leong WF, Li B (2009) Signaling pathways governing osteoblast proliferation, differentiation and function. Histol Histopathol 24:1593–1606
Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812–821
Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420–430
Sun X, Cao Z, Zhang Q, Liu S, Xu F, Che J, Zhu Y, Li Y, Pan C, Liang W (2015) Aluminum trichloride impairs bone and downregulates wnt/β-catenin signaling pathway in young growing rats. Food Chem Toxicol 86:154–162
Caverzasio J, Biver E, Thouverey C (2013) Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation. J Bone Miner Res 28:260–270
Zhang J, Shao Y, He D, Zhang L, Xu G, Shen J (2016) Evidence that bone marrow-derived mesenchymal stem cells reduce epithelial permeability following phosgene-induced acute lung injury via activation of wnt3a protein-induced canonical wnt/β-catenin signaling. Inhal Toxicol 19:1–8
Cao Z, Liu D, Zhang Q, Sun X, Li Y (2016) Aluminum chloride induces osteoblasts apoptosis via disrupting calcium homeostasis and activating Ca(2+)/CaMKII signal pathway. Biol Trace Elem Res 169:247–253
Pan L, Shi X, Liu S, Guo X, Zhao M, Cai R, Sun G (2014) Fluoride promotes osteoblastic differentiation through canonical wnt/β-catenin signaling pathway. Toxicol Lett 225:34–42
Li M, Song M, Ren LM, Xiu CY, Liu JY, Zhu YZ, Li YF (2016) AlCl3 induces lymphocyte apoptosis in rats through the mitochondria-caspase dependent pathway. Environ Toxicol 31:385–394
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
Goodman WG (1985) Bone disease and aluminum: pathogenic considerations. Am J Kidney Dis 6:330–335
Quarles LD, Wenstrup RJ, Castillo SA, Drezner MK (1991) Aluminum-induced mitogenesis in MC3T3-E1 osteoblasts: potential mechanism underlying neoosteogenesis. Endocrinology 128:3144–3151
Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a wnt coreceptor. J Cell Biol 157:303–314
Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO (2004) Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 19(12):2033–2040
Reischmann P, Fiebeck J, von der Weiden N, Müller O (2015) Measured effects of Wnt3a on proliferation of HEK293T cells depend on the applied assay. Int J Cell Biol 2015:928502
Niehrs C, Acebron SP (2012) Mitotic and mitogenic wnt signaling. EMBO J 31:2705–2713
McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Abrams SL, Montalto G, D’Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Cocco L, Cervello M, Martelli AM (2014) Multifaceted roles of GSK-3 and wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia 28:15–33
Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F (1997) The mouse fused locus encodes Axin, an inhibitor of the wnt signaling pathway that regulates embryonic axis formation. Cell 90:181–192
Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J (2012) MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Biochem Biophys Res Commun 28:525–531
Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T (2006) Differentiation-inducing factor-1 alters canonical wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines. J Bone Miner Res 21:1307–1316
Chen JR, Lazarenko OP, Wu X, Kang J, Blackburn ML, Shankar K, Badger TM, Ronis MJ (2010) Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical wnt signaling. J Bone Miner Res 25:2399–2411
López-Herradón A, Portal-Núñez S, García-Martín A, Lozano D, Pérez-Martínez FC, Ceña V, Esbrit P (2013) Inhibition of the canonical wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells. J Cell Biochem 114:1908–1916
Lei B, Chai W, Wang Z, Liu R (2015) Highly expressed UNC119 promotes hepatocellular carcinoma cell proliferation through wnt/β-catenin signaling and predicts a poor prognosis. Am J Cancer Res 5:3123–3134
Chen Y, Jiang T, Shi L, He K (2016) hcrcn81 promotes cell proliferation through wnt signaling pathway in colorectal cancer. Med Oncol 33:3
Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677
Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348
Ruggero D (2009) The role of myc-induced protein synthesis in cancer. Cancer Res 69:8839–8843
Cole MD, Cowling VH (2008) Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol 9:810–815
Daksis JI, Lu RY, Facchini LM, Marhin WW, Penn LJ (1994) Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635–3645
Arioka M, Takahashi-Yanaga F, Sasaki M, Yoshihara T, Morimoto S, Takashima A, Mori Y, Sasaguri T (2013) Acceleration of bone development and regeneration through the wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β. Biochem Biophys Res Commun 440:677–682
Liu M, Sun Y, Liu Y, Yuan M, Zhang Z, Hu W (2012) Modulation of the differentiation of dental pulp stem cells by different concentrations of β-glycerophosphate. Molecules 17:1219–1232
Acknowledgments
This work was supported by National Natural Science Foundation Project (contract grant numbers 31372496 and 31302147) and the National Science Foundation of Fujian Province of China (2013J0102).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Huang, W., Wang, P., Shen, T. et al. Aluminum Trichloride Inhibited Osteoblastic Proliferation and Downregulated the Wnt/β-Catenin Pathway. Biol Trace Elem Res 177, 323–330 (2017). https://doi.org/10.1007/s12011-016-0880-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-016-0880-3